New polycyclic tetramate macrolactams with antimycobacterial activity produced by marine-derived Streptomyces sp.
Satoru Shigeno1,2, Miyu Kadowaki1,2, Kenichiro Nagai2
1Department of Microbial Chemistry, Graduate School of Pharmaceutical Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641, Japan.
Abstract:
During our screening for anti-mycobacterial agents against Mycobacterium avium complex (MAC), two new polycyclic tetramate macrolactams (PTMs), named hydroxycapsimycin (1) and brokamycin (2), were isolated along with the known PTM, ikarugamycin (3), from the culture broth of marine-derived Streptomyces sp. KKMA-0239. The relative structures of 1 and 2 were elucidated by spectroscopic data analyses, including 1D and 2D NMR. Furthermore, the absolute configuration of 1 was confirmed by a single-crystal X-ray diffraction analysis. Compounds 2 and 3 exhibited moderate antimycobacterial activities against MAC, including clinically isolated drug-resistant M. avium.
Related Concept Videos
Bacterial Phylum Planctomycetes
Bacterial Phylum Actinobacteria
Production of Antibiotics
Inhibitors of Gram-positive Cell Wall Synthesis
Antifungal Agents
Clinical Significance of Antibiotic Resistance


